Suprachoroidal Tyrosinase Therapy of Neovascular AMD
Retina Synthesis - Un pódcast de Retina Synthesis
Categorías:
We discuss the use of a suprachoroidal delivery system for delivery of tryrosinase kinase inhibitor for the treatment of neovascular AMD with Dr. Thomas Ciulla, Chief Development Officer, Chief Medical Officer, Clearside Biomedical.
